Biosimilars and Interchangeable Biologics: Strategic Elements Sarfaraz K. Niazi 2016 - 1st 20 % تخفیف Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. اطلاعات بیشتر نمایش داده شود
Sarfaraz K. Niazi
20 % تخفیف
اطلاعات بیشتر نمایش داده شود